含羞草社区

?
?
?
Home Tags Posts tagged with "Gaush Meditech"

Tag: Gaush Meditech

Law firm quartet advises Gaush Meditech’s Hong Kong listing

Gaush Meditech, the fourth largest ophthalmic medical device company in China, raised HKD672 million (USD86.34 million) in its Hong Kong listing, offering a total of 13.06 million shares at HKD51.4 per share

MOST READ ON LAW.ASIA

Trade secrecy laws in Taiwan

By Tsung-Yuan Shen and Connie Guo, Lee and Li Taipei

Trade secret protection under TSA and IPCAA: Secrecy, value, confidentiality measures and Supreme Court guidance

konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW

Don’t judge land by its title: Lessons from spouses Manalese v Ferreras

By Nilo?T Divina, Ciselie?Marie T Gamo-Sisayan?and Angel Isah M Romero, DivinaLaw

CCI emphasises value of AI self-audit

By Ram Kumar Poornachandran, Anjali Kumar, Pavan Kalyan and Palak Jagetia, AZB & Partners

Correspondents

Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW

Follow us on LinkedIn